Oxbridge Re (NASDAQ:OXBR – Get Free Report) is expected to be posting its Q1 2026 results after the market closes on Monday, May 11th. Analysts expect Oxbridge Re to post earnings of ($0.03) per share and revenue of $0.70 million for the quarter. Individuals are encouraged to explore the company’s upcoming Q1 2026 earning overview page for the latest details on the call scheduled for Monday, May 11, 2026 at 4:30 PM ET.
Oxbridge Re (NASDAQ:OXBR – Get Free Report) last posted its quarterly earnings results on Saturday, February 14th. The insurance provider reported $0.02 EPS for the quarter. The company had revenue of $0.58 million during the quarter. Oxbridge Re had a negative net margin of 80.68% and a negative return on equity of 34.45%.
Oxbridge Re Trading Down 1.0%
Shares of Oxbridge Re stock opened at $0.97 on Friday. The company’s fifty day simple moving average is $0.89 and its two-hundred day simple moving average is $1.15. The company has a market cap of $7.86 million, a P/E ratio of -3.59 and a beta of 2.05. Oxbridge Re has a 12-month low of $0.66 and a 12-month high of $2.86.
Analyst Upgrades and Downgrades
Read Our Latest Stock Analysis on Oxbridge Re
Institutional Trading of Oxbridge Re
A hedge fund recently raised its stake in Oxbridge Re stock. J.W. Cole Advisors Inc. boosted its position in Oxbridge Re Holdings Limited (NASDAQ:OXBR – Free Report) by 106.1% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 68,000 shares of the insurance provider’s stock after purchasing an additional 35,000 shares during the quarter. J.W. Cole Advisors Inc. owned approximately 0.89% of Oxbridge Re worth $90,000 at the end of the most recent reporting period. 5.64% of the stock is owned by institutional investors.
Oxbridge Re Company Profile
Oxbridge Re Holdings Limited (NASDAQ: OXBR) is a reinsurance holding company that provides capital solutions and risk-sharing arrangements to insurance carriers. Its core business centers on offering treaty reinsurance and structured transactions designed to help insurers manage underwriting exposures and optimize their capital efficiency. By leveraging tailored financing structures, Oxbridge Re enables clients to transfer segments of their in-force life and health insurance portfolios, freeing up capital for growth or other strategic initiatives.
The company’s products and services include quota share reinsurance, coinsurance, and loss portfolio transfers, each crafted to address specific balance sheet and earnings targets of cedents.
Read More
Receive News & Ratings for Oxbridge Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxbridge Re and related companies with MarketBeat.com's FREE daily email newsletter.
